Negotiated reimbursement rates for D0482 across 3 states, sourced from CMS Transparency in Coverage data. 13 rate records.
D0482 pertains to Direct Immunofluorescence, a diagnostic procedure that utilizes fluorescently labeled antibodies to detect specific antigens in tissue samples. This method is particularly effective in diagnosing autoimmune diseases, infections, and certain malignancies. Clinical indications for this procedure include conditions such as pemphigus vulgaris, lupus erythematosus, and other disorders where antigen identification is crucial. Proper documentation is vital, including the clinical history, indications for the test, and any relevant findings. The average reimbursement for D0482 is approximately $97, but this can vary widely among different payors and states. Some insurance companies may have specific criteria for coverage, and it is advisable to check individual policies to ensure compliance and maximize reimbursement.
Reimbursement rates for D0482 vary significantly by state, payor, and provider network. The national average negotiated rate is $97. Data sourced from CMS Transparency in Coverage machine-readable files, updated monthly.
0+ more states available with Pro ↓